Back to Clinical Trials

Clinical Trials: Genito-Urinary Medicine


Source: Gustave Roussy, Cancer Campus, Grand Paris
Toward personalised treatment in early metastatic prostate cancer based on the assessment of biomarkers in cancer tissue samples and circulating tumour cells. Read More
Last Updated: 04 Feb 2016
Source: Niguarda Hospital
The aim of this study is to compare the incidence of genito-urinary function depression and anastomotic leak in Laparoscopic Anterior Rectal Resection (LAR) with Total Mesorectal Excision with Ligation if the Inferior Mesenteric Artery at the origin or preserving the Left Colic Artery by a prospective randomized trial. Read More
Last Updated: 18 Feb 2015
Source: Spanish Oncology Genito-Urinary Group
Main Objective: To evaluate progression-free survival in patients with unresectable renal cell carcinoma (RCC) treated with a combination of gemcitabine, capecitabine, and sorafenib. Read More
Last Updated: 12 Jan 2009
Source: Spanish Oncology Genito-Urinary Group
Safety profile and to determine maximum tolerated dose of Sorafenib in combination with Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent Read More
Last Updated: 30 Sep 2014
Source: Spanish Oncology Genito-Urinary Group
The purpose of this trial is to determinate the efficacy of Sunitinib in patients with renal cells carcinoma metastasic or locally avanced in patints not candidates to inicial curative nefrectomy. Read More
Last Updated: 16 Dec 2014
Source: Spanish Oncology Genito-Urinary Group
- Design: non-randomized, open label, phase II clinical trial. - Study population and disease: adult patients with metastatic or locally advanced non-resectable adrenocortical carcinoma, confirmed histologically. - Estimated number of patients: 15. - Study drug: dovitinib (TKI-258), dosed on a flat scale of 500mg/day on a 5 days on / 2 days off. - Treatment duration: study treatment period will be continued until disease ... Read More
Last Updated: 13 Apr 2016
Source: Istituto Clinico Humanitas
This is a prospective, multicentric, phase II and feasibility study aimed to address early and late side effects of hypofractionated ablative radiotherapy for oligometastatic patients with lymph node metastases for genito-urinary, gastro-intestinal and gynaecological cancer. Read More
Last Updated: 04 Oct 2015
Source: Spanish Oncology Genito-Urinary Group
Phase I / II, open, prospective, multicenter single-arm, Clinical Trial in two stages: in the first stage it will determine the optimal dose of the combination of pazopanib and interferon alfa-A2 in the treatment of patients with advanced renal carcinoma and a second stage that will determine the efficacy of this combination measured in terms of response rate. Read More
Last Updated: 15 Dec 2015
Source: Johns Hopkins University
This research is being done to learn more about the bacteria that live in the genito-urinary tract in subjects with urologic chronic pelvic pain syndrome (UCPPS). Read More
Last Updated: 17 Jan 2017
Source: Technische Universität Dresden
ProtoChoice-P is a prospective multicenter trial to evaluate proton therapy in patients suffering from prostate cancer. Primary aim of the study is a decrease of moderate or severe genito-urinary or intestinal side effects (Common Terminology Criteria for Adverse Events (CTCAE) 4.0 grade 2 or higher) by the use of proton therapy. Secondary endpoints contain assessment of quality of life, biochemical recurrence and recurrence free survival as well as overall ... Read More
Last Updated: 12 Sep 2016
Source: University College London Hospitals
To determine the adverse events and genito-urinary side-effect profile of focal therapy to treat localised low to intermediate risk prostate cancer using irreversible electroporation (Nanoknife™). Read More
Last Updated: 16 Jun 2014
Source: Assiut University
The aim of this study is to identify demographic & disease characteristics in pediatric oncology patients diagnosed with one of genitourinary tumors & treatment outcomes in these patients. Read More
Last Updated: 25 Oct 2016
Source: Spanish Oncology Genito-Urinary Group
Prospective observational study to assess bone predictive biomarkers for TKI response in RCC patients with bone metastasis and HRQoL with TKI in these patients as well as the sensitivity and specificity of whole body magnetic resonance versus bone scintigraphy and versus CT in the assessment of metastatic lesions at bone level and at other sites. Read More
Last Updated: 17 Apr 2016
Source: Spanish Oncology Genito-Urinary Group
The purpose of this retrospective observational study was to analyze the effect of targeted therapies administered as second-line treatment after failure of pazopanib as well as increase the amount of information available on efficacy and safety of pazopanib as a first-line therapy in practice usual for the clinical treatment of metastatic Renal Carcinoma. Read More
Last Updated: 06 May 2015
Source: Assiut University
Many oral analgesic drugs such as nonsteroidal anti-inflammatory drug(NSAID) are used to relieve pain from gynecological procedure and dysmenorrhea. Hyoscine-N-butyl bromide, an antispasmodic drug are commonly used for relief of smooth muscle spasms and can use to relieve genito-urinary spasm. Some studies reported hyoscine can't relieve pain in minor gynecological procedures. So the efficacy of hyoscine use are still controversial and no previous studies ... Read More
Last Updated: 05 Sep 2016
Source: Spanish Oncology Genito-Urinary Group
This is a clinical trial to evaluate the efficacy and safety of the drug vinflunine administered after the standard treatment of the combination gemcitabine+cisplatin, when it has reached stabilization or response of the disease, as the first treatment inmeditely after the diagnosis of advanced or metastatic urothelial cancer. Read More
Last Updated: 16 Dec 2014
Source: Center Eugene Marquis
This study evaluates the effect of adaptative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of locally advanced cervical cancer on acute genito-urinary (GU), and gastrointestinal (GI) toxicities. Every patients will be treated according to the adaptative IMRT strategy. Read More
Last Updated: 21 Dec 2016
Source: Spanish Oncology Genito-Urinary Group
Penile cancer is an uncommon disease, with devastating physical and psychological effects on patients. Penile carcinoma even in advanced stages is responsive to several chemotherapeutic agents. However, due to the low incidence of penile cancer, no large studies have been reported concerning chemotherapy. Various single agents were tested for activity en penile cancer in de 70s and 80s. Response rates ranged from 10 to 27% with cisplatin, 20 to 21% with ... Read More
Last Updated: 12 Oct 2016
Source: Boehringer Ingelheim
The purpose of this study was to determine the effects of nevirapine treatment on the pharmacokinetics of methadone in HIV-1 infected, opioid-dependent adults who had been on a stable methadone maintenance therapy for at least five days prior to study entry. Read More
Last Updated: 29 Oct 2013
Source: Spanish Oncology Genito-Urinary Group
This is a multicenter open label non randomized phase II clinical trial of Weekly Cabazitaxel for Advanced Prostate Cancer in Hormone-Refractory Patients Previously Treated with Docetaxel. The purpose of this study is to evaluate the activity of the weekly administration of cabazitaxel as time to progression by PSA at week 12. Read More
Last Updated: 12 Oct 2016
Page 1 of 50